Article

Managing Side Effects of mTOR Inhibitors in Cancer

Naomi Haas, of the Abramson Cancer Center, explains the potential side effects of a class of drugs called mTOR inhibitors, primarily the agents Sutent and Nexavar.

Naomi Haas, of the Abramson Cancer Center, explains the potential side effects of a class of drugs called mTOR inhibitors, primarily the agents Sutent (sunitinib) and Nexavar (sorafenib). mTOR inhibitors target the blood vessels, but they also have other effects, Haas says.

Common side effects may include high blood pressure, fatigue, diarrhea and hand-foot syndrome.

"They are actually very manageable if they are reported early," she says. "What I recommend is that patients go over these side effects up front. We encourage patients to monitor their blood pressure. We encourage them to call early if they get any signs of these symptoms or discomfort." Dose adjustments and supportive care are two ways to manage potential side effects, she notes.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of bald man.
Image of man.
Image of Kumar.
Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.
Melanoma is a key cancer type for developing and testing immunotherapies prior to broader clinical application across other malignancies.
Image of Dr. Kumar.
Photo of a woman with shoulder-length black hair wearing a blazer
Image of a woman wearing a headband and glasses
Image of man.
Related Content